Medipharm Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Overnight that washington could be delaying easing up restrictions on huawei as part of the trade war deepening tensions potentiallimentpotentially ment and we have the s p 500 and the dow coming off some highs yesterday. Overnight in asia, we had some interesting news out of japan. Theyre changing the way theyre buying maturities across the yield curve. We have the nikkei higher by 0. 4 we have red arrows on the hang seng and shanghai. New china data overnight that showed food prices surging 9 , largely in part due to a surge in vegetable and pork prices european equities, down arrows across ...

/PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized...

MediPharm Labs (OTCMKTS: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products for the Brazilian medical cannabis market. MediPharm has already received GMP certifications from the US FDA, the European Union, and Australia's TGA, and holds a drug establishment license from Health Canada. The Brazilian medical cannabis market is projected to reach CAD380m (USD282m) by 2025, according to industry forecasts. MediPharm Labs, which already produces two medical cannabis ...

MediPharm Labs (OTCMKTS:MEDIF – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Institutional and Insider Ownership 75.9% of Lifecore Biomedical […]